Status: current, Defined. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4825471000168118 | lenacapavir 463.5 mg / 1.5 mL injection, 1.5 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4825481000168115 | lenacapavir 463.5 mg/1.5 mL injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| lenacapavir 463.5 mg/1.5 mL injection, vial | Is a | lenacapavir | true | Inferred relationship | Some | ||
| lenacapavir 463.5 mg/1.5 mL injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| lenacapavir 463.5 mg/1.5 mL injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| lenacapavir 463.5 mg/1.5 mL injection, vial | has unit of use | vial | true | Inferred relationship | Some | 282374225 | |
| lenacapavir 463.5 mg/1.5 mL injection, vial | has intended active ingredient | lenacapavir | true | Inferred relationship | Some | 250352677 | |
| lenacapavir 463.5 mg/1.5 mL injection, vial | has Australian BoSS | lenacapavir | true | Inferred relationship | Some | 250352677 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Sunlenca 463.5 mg/1.5 mL injection, 1.5 mL vial | Is a | True | lenacapavir 463.5 mg/1.5 mL injection, vial | Inferred relationship | Some | |
| lenacapavir 463.5 mg/1.5 mL injection, 2 x 1.5 mL vials | has MPUU | True | lenacapavir 463.5 mg/1.5 mL injection, vial | Inferred relationship | Some | 1813086129 |
Reference Sets
Medicinal product unit of use reference set
FHIR